Skip to content

Study on the relationship between emboli components and inflammatory and coagulation indexes in blood and clinical outcomes in patients with cerebral embolism

Study on the relationship between emboli components and inflammatory and coagulation indexes in blood and clinical outcomes in patients with cerebral embolism

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200057600
Enrollment
Unknown
Registered
2022-03-15
Start date
2022-02-28
Completion date
Unknown
Last updated
2023-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral embolism

Interventions

Good prognosis group:NIHSS change 2

Sponsors

Beijing Luhe Hospital Affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. 18 years of age or older for men and women; 2. The clinical diagnosis was in line with the diagnostic criteria of cerebral infarction formulated by the Fourth National Conference on cerebrovascular diseases; 3. All patients were confirmed by head CT/MRI, and underwent emergency thrombectomy to remove the thrombus; 4. Understand and be willing to participate in this clinical study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Intracranial hemorrhage in cerebral parenchyma, subarachnoid space, subdural and epidural space; 2. The life expectancy is less than 1 year in the advanced stage of malignant tumor or in the failure stage of serious lesions of other organs.

Design outcomes

Primary

MeasureTime frame
Change of NIHSS (National Institute of Health stroke scale) value;Value of Modified Rankin Scale;

Countries

China

Contacts

Public ContactYanling Wang

Beijing Luhe Hospital Affiliated to Capital Medical University

songfengzhuming@163.com+86 13717601786

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026